Skip to content

Identification of Heart Failure Patients by Seismocardiography

Identification of Heart Failure Patients by Seismocardiography; a Comparison With Echocardiography and Brain Natriuretic Peptide

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03656354
Acronym
SCG-HF
Enrollment
219
Registered
2018-09-04
Start date
2018-06-29
Completion date
2022-07-27
Last updated
2023-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

seismocardiography

Brief summary

The aim of the current study is to develop and validate an algorithm based on seismocardiography recordings to detect heart failure. Echocardiography will be used as the golden standard for defining patients with heart failure.

Detailed description

Seismocardiography is inspired from methods for the analysis of seismic activity and can be used to describe the heart's movements using a specially developed sensor placed on the patient's chest. The project aims to describe the motion of the heart using automated computer analysis of the seismocardiography signal for development of a simple method for the analysis of myocardial performance.

Interventions

DEVICESeismocardiography

Seismocardiography recording

Sponsors

Acarix
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female, aged 18 years or older * Clinically suspected heart failure, and referred to an outpatient clinic * Be able and willing to comply with the clinical investigational plan * Have signed the informed consent form

Exclusion criteria

* Known HF * Known atrial fibrillation * Acute coronary syndrome * Implanted donor heart, mechanical heart, mechanical heart pump, pacemaker or Cardioverter Defibrillator (ICD) * Implanted electronic equipment in the area above and around the heart * Significant operation scars, abnormal body shape, fragile or compromised skin in the seismocardiographic recording area (fourth left Inter Costal space and xiphoid process) * Pregnancy Extension study: Inclusion criteria 1. Male or female, aged 18 years or older 2. Newly diagnosed HFREF 3. Be able and willing to comply with the clinical investigational plan 4. Have signed the informed consent form

Design outcomes

Primary

MeasureTime frameDescription
Area under the receiver-operator characteristic curve, sensitivity, specificity, and positive and negative predictive value of seismocardiography in detection of heart failure.1 dayHeart failure defined as heart failure with reduced ejection fraction, heart failure with mid-range ejection fraction and heart failure with preserved ejection fraction combined.

Secondary

MeasureTime frameDescription
Area under the receiver-operator characteristic curve, sensitivity, specificity, and positive and negative predictive value of seismocardiography and NT-proBNP, respectively, in detection of heart failure with reduced ejection fraction1 day
Area under the receiver-operator characteristic curve, sensitivity, specificity, and positive and negative predictive value of seismocardiography in detection of heart failure with mid-range ejection fraction.1 day
Area under the receiver-operator characteristic curve, sensitivity, specificity, and positive and negative predictive value of seismocardiography in detection of heart failure with preserved ejection fraction.1 day
Adverse events related to the CADScor seismo device.1 dayCount of adverse events

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026